Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Laser crossectomy with 1470 nm versus 1940 nm to prevent varicose vein recurrence

Official title: The Influence of Laser Crossectomy With Different Wavelengths on Varicose Vein Progression

Run by Pirogov Russian National Research Medical University · NCT07449728 · Data updated 2026-11-12

This will test whether doing a flush laser crossectomy with either a 1470 nm or 1940 nm laser lowers the chance of varicose vein recurrence and heat-related clots in adults with great saphenous vein reflux.

More Varicose Veins of Lower Limb trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment400 (estimated)
SponsorPirogov Russian National Research Medical University
Academic / other
Locations1 site (Moscow)
StatusRecruiting
StartedJanuary 20, 2026
Main results expectedJanuary 20, 2028
Study endsJanuary 20, 2029
Registry record updatedMarch 4, 2026
Trial IDNCT07449728 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults over 18 with primary varicose veins (CEAP C2–C6), documented great saphenous vein reflux >0.5 seconds, GSV diameter ≤12 mm, and ability to consent and attend follow-up are ideal candidates.

Probably not a fit

Patients with reflux outside the GSV, prior deep or superficial vein thrombosis, deep venous reflux, pelvic venous insufficiency, current anticoagulant use, or need for pharmacologic prophylaxis are excluded and unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with primary great saphenous vein reflux (CEAP C2–C6, GSV diameter ≤12 mm, reflux >0.5 s) will receive one of three endovenous approaches: laser crossectomy with 1470 nm, laser crossectomy with 1940 nm, or standard endovenous laser treatment leaving a stump. The trial compares technical success, recurrence at the sapheno-femoral junction, postoperative pain intensity, and rates of endovenous heat-induced thrombosis using clinical and ultrasound follow-up. Investigators expect similar technical efficacy between the two wavelengths but will look for differences in pain and adverse events. Procedures are performed at a single center with standard exclusion criteria to reduce thrombotic risk and with informed consent.

Why it matters

Potential benefit: If successful, the approach could lower recurrence at the sapheno-femoral junction and reduce postoperative pain or endovenous heat-induced thrombosis after EVLT.

How similar studies have gone: Endovenous laser treatment is an established alternative to open surgery, but direct comparisons of flush laser crossectomy at 1470 nm versus 1940 nm are limited and this specific comparison is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age \>18 years
* Primary VVs of Clinical Etiology Anatomy Pathophysiology (CEAP) clinical class of C2-C6
* Reflux along the GSV trunk lasting \>0.5 sec.
* GSV trunk diameter ≤12 mm
* Informed consent to participate in the study

Exclusion Criteria:

* Primary reflux outside the GSV trunk (including combined reflux)
* History of deep or superficial vein thrombosis
* Deep vein reflux
* Non-thrombotic or post-thrombotic venous obstruction
* Pelvic venous insufficiency
* Use of oral anticoagulants
* Indication for pharmacological prophylaxis after EVLT
* Inability to use radial fiber of 1.4-1.57 mm at the surgeon's discretion
* Refusal to participate in the study

Where it's running

  • MedSwiss Private Cinic
    Moscow, Russia
    Recruiting

Study contacts

  • Principal investigator: Kirill Lobastov, PhD — Pirogov Russian National Research Medical University
  • Study coordinator: Kirill Lobastov, PhD
  • Email: lobastov_kv@hotmail.com
  • Phone: +79852116331

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.